Medicine
Methimazole 10 mg tablet
Methimazole 10 mg tablet is a generic prescription medicine for oral use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Methimazole
- Brand
- Sold under the generic name
- Strength
- 10 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 10 blister pack and 42 more
- Manufacturers
- Macleods PharmaceuticalsIndiaAvet PharmaceuticalsIndiaStrides PharmaIndiaViona PharmaceuticalsIndiaBryant Ranch PrepackChartwell RXPreferred PharmaceuticalsAiPing PharmaceuticalAmerican Health PackagingAvKARE20 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H03BB02 Methimazole
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 March 2001
- Identifiers
- RxCUI 197941, 197942DailyMed set ID f74a8e69-79a1-4061-b42f-447e0780c04f, 1f6970fb-a549-47b0-b812-48109521d713, 3f65518b-33da-48d8-9af2-2a750400b401 +24NDC 71335-2218, 71335-2906, 71335-3027 +24Application ANDA202068, ANDA040350, ANDA040547 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 20 labelers. The register lists 45 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 23155-071-01 | Avet PharmaceuticalsIndia | 15 January 2012 |
| 1000 tablet in 1 bottle | 23155-071-10 | Avet PharmaceuticalsIndia | 15 January 2012 |
| 100 tablet in 1 bottle | 33342-336-11 | Macleods PharmaceuticalsIndia | 24 May 2023 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 33342-336-12 | Macleods PharmaceuticalsIndia | 24 May 2023 |
| 1000 tablet in 1 bottle | 33342-336-44 | Macleods PharmaceuticalsIndia | 24 May 2023 |
| 100 tablet in 1 bottle | 64380-213-01 | Strides PharmaIndia | 14 March 2022 |
| 500 tablet in 1 bottle | 64380-213-02 | Strides PharmaIndia | 28 February 2024 |
| 100 tablet in 1 bottle | 72578-213-01 | Viona PharmaceuticalsIndia | 10 September 2025 |
| 100 tablet in 1 bottle | 11788-012-01 | AiPing Pharmaceutical | 1 April 2026 |
| 500 tablet in 1 bottle | 11788-012-05 | AiPing Pharmaceutical | 28 August 2026 |
| 100 tablet in 1 bottle | 69452-329-20 | Bionpharma | 25 March 2024 |
| 100 tablet in 1 bottle | 62135-206-01 | Chartwell RX | 4 November 2021 |
| 180 tablet in 1 bottle | 62135-206-18 | Chartwell RX | 4 November 2021 |
| 30 tablet in 1 bottle | 62135-206-30 | Chartwell RX | 4 November 2021 |
| 90 tablet in 1 bottle | 62135-206-90 | Chartwell RX | 4 November 2021 |
| 100 tablet in 1 bottle | 64980-265-01 | Rising Pharma Holdings | 22 April 2021 |
| 100 tablet in 1 bottle | 76483-083-00 | Square Pharmaceuticals | 31 December 2024 |
| 100 tablet in 1 bottle | 0832-6073-11 | Upsher-Smith Laboratories | 22 March 2024 |
| 100 tablet in 1 bottle | 63629-9251-1 | Bryant Ranch Prepack | 28 March 2022 |
| 30 tablet in 1 bottle | 71335-0883-1 | Bryant Ranch Prepack | 25 June 2018 |
| 15 tablet in 1 bottle | 71335-0883-2 | Bryant Ranch Prepack | 29 November 2018 |
| 90 tablet in 1 bottle | 71335-0883-3 | Bryant Ranch Prepack | 10 September 2020 |
| 30 tablet in 1 bottle | 71335-2218-1 | Bryant Ranch Prepack | 31 August 2023 |
| 15 tablet in 1 bottle | 71335-2218-2 | Bryant Ranch Prepack | 31 August 2023 |
| 90 tablet in 1 bottle | 71335-2218-3 | Bryant Ranch Prepack | 31 August 2023 |
| 30 tablet in 1 bottle | 71335-2349-1 | Bryant Ranch Prepack | 21 February 2024 |
| 15 tablet in 1 bottle | 71335-2349-2 | Bryant Ranch Prepack | 21 February 2024 |
| 90 tablet in 1 bottle | 71335-2349-3 | Bryant Ranch Prepack | 21 February 2024 |
| 100 tablet in 1 bottle | 71335-2906-1 | Bryant Ranch Prepack | 6 November 2025 |
| 180 tablet in 1 bottle | 71335-3027-1 | Bryant Ranch Prepack | 3 December 2025 |
| 100 tablet in 1 bottle | 72162-1803-1 | Bryant Ranch Prepack | 30 March 2023 |
| 180 tablet in 1 bottle | 72162-1803-2 | Bryant Ranch Prepack | 15 April 2025 |
| 100 tablet in 1 bottle | 68788-4063-1 | Preferred Pharmaceuticals | 28 January 2026 |
| 30 tablet in 1 bottle | 68788-4063-3 | Preferred Pharmaceuticals | 28 January 2026 |
| 100 tablet in 1 bottle | 68788-8227-1 | Preferred Pharmaceuticals | 8 August 2022 |
| 30 tablet in 1 bottle | 68788-8227-3 | Preferred Pharmaceuticals | 8 August 2022 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 60687-680-01 | American Health Packaging | 30 March 2023 |
| 100 tablet in 1 bottle | 73190-085-01 | AvKARE | 15 June 2026 |
| 50 blister pack in 1 box / 1 tablet in 1 blister pack | 50268-496-15 | AvPAK | 13 October 2025 |
| 30 tablet in 1 blister pack | 67046-1652-3 | Coupler | 23 January 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 June 1950 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Methimazole
Clinical summary
Methimazole is a thyroid hormone synthesis inhibitor indicated in patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option. MedsAcross supplies Methimazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethimazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Methimazole prescribing information (AiPing Pharmaceutical) · U.S. National Library of Medicine, DailyMed
Need Methimazole 10 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.